Primary |
Hypertension |
11.9% |
Drug Use For Unknown Indication |
10.2% |
Langerhans' Cell Histiocytosis |
10.2% |
Wound Complication |
10.2% |
Cerebral Infarction |
5.1% |
Constipation |
5.1% |
Convulsion Prophylaxis |
5.1% |
Infection |
5.1% |
Insomnia |
5.1% |
Cardiovascular Insufficiency |
3.4% |
Fluid Replacement |
3.4% |
Lung Adenocarcinoma Metastatic |
3.4% |
Pyrexia |
3.4% |
Sputum Retention |
3.4% |
Stress Ulcer |
3.4% |
Tooth Abscess |
3.4% |
Tumour Associated Fever |
3.4% |
Asthma |
1.7% |
Gastritis |
1.7% |
Hepatic Function Abnormal |
1.7% |
|
Renal Failure Chronic |
33.3% |
Histiocytosis Haematophagic |
16.7% |
Bone Tuberculosis |
8.3% |
Hypoaesthesia |
8.3% |
Overdose |
8.3% |
Purpura Fulminans |
8.3% |
Sepsis |
8.3% |
Stevens-johnson Syndrome |
8.3% |
|
Secondary |
Drug Use For Unknown Indication |
16.0% |
Asthma |
12.0% |
Anxiety |
8.0% |
Colon Cancer Metastatic |
8.0% |
Lung Neoplasm Malignant |
6.0% |
Anorexia |
4.0% |
Back Pain |
4.0% |
Depression |
4.0% |
Gastric Mucosal Lesion |
4.0% |
Large Intestine Carcinoma |
4.0% |
Nasopharyngitis |
4.0% |
Pain |
4.0% |
Pneumonia |
4.0% |
Product Used For Unknown Indication |
4.0% |
Systemic Lupus Erythematosus |
4.0% |
Constipation |
2.0% |
Diabetes Mellitus |
2.0% |
Febrile Neutropenia |
2.0% |
Gastric Ulcer |
2.0% |
Gastritis |
2.0% |
|
Eyelid Oedema |
22.2% |
Gastric Ulcer |
11.1% |
Gastric Ulcer Haemorrhage |
11.1% |
Large Intestine Perforation |
11.1% |
Liver Abscess |
11.1% |
Melaena |
11.1% |
Pyrexia |
11.1% |
Renal Failure Acute |
11.1% |
|
Concomitant |
Prophylaxis |
19.3% |
Product Used For Unknown Indication |
11.0% |
Drug Use For Unknown Indication |
8.3% |
Juvenile Arthritis |
8.1% |
Cancer Pain |
6.0% |
Constipation |
5.1% |
Metastatic Renal Cell Carcinoma |
4.6% |
Colorectal Cancer |
4.5% |
Hepatic Neoplasm Malignant |
4.4% |
Tumour Associated Fever |
4.3% |
Chronic Hepatitis C |
4.0% |
Renal Cell Carcinoma |
3.6% |
Hypertension |
3.5% |
Rheumatoid Arthritis |
2.3% |
Relapsing-remitting Multiple Sclerosis |
2.0% |
Gastritis |
1.9% |
Diabetes Mellitus |
1.8% |
Pain |
1.8% |
Gastritis Prophylaxis |
1.7% |
Pyrexia |
1.7% |
|
Pyrexia |
12.0% |
Platelet Count Decreased |
10.9% |
Tumour Lysis Syndrome |
9.7% |
Rash |
6.3% |
Hypoproteinaemia |
5.7% |
White Blood Cell Count Increased |
5.7% |
Stomatitis |
5.1% |
Vomiting |
4.6% |
Hepatic Function Abnormal |
4.0% |
Pneumonia |
4.0% |
Renal Impairment |
4.0% |
White Blood Cell Count Decreased |
4.0% |
Interstitial Lung Disease |
3.4% |
Lung Disorder |
3.4% |
Multiple Sclerosis Relapse |
3.4% |
Palpitations |
2.9% |
Pneumothorax |
2.9% |
Renal Cell Carcinoma |
2.9% |
Weight Decreased |
2.9% |
Haematochezia |
2.3% |
|